Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Sanxin Industrial Group is a diversified conglomerate based in Shijiazhuang, China, with a significant presence in the pharmaceutical and healthcare sectors. The company operates primarily through its subsidiary, Hebei Sanxin Pharmaceutical, which specializes in the production of chemical drugs and Traditional Chinese Medicines (TCM). Its extensive product portfolio includes various formulations such as injections, tablets, and capsules, targeting therapeutic areas like cardiovascular and cerebrovascular diseases. Key commercial products include Alprostadil for vascular conditions and Oxiracetam for neurological support. Beyond pharmaceuticals, the group is involved in medical device manufacturing, real estate development, and international trade. The company's manufacturing facilities are GMP-certified, ensuring high-quality production standards for the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei SanXin Industrial Group.